featured
DKA With Canagliflozin in Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
Diabetes Care 2016 Mar 17;[EPub Ahead of Print], AL Peters, RR Henry, P Thakkar, C Tong, M AlbaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.